A quantitative structure-activity relationship study on some HIV-1 protease inhibitors using molecular connectivity index

被引:37
作者
Gayathri, P
Pande, V
Sivakumar, R
Gupta, SP [1 ]
机构
[1] Birla Inst Technol & Sci, Dept Chem, Pilani 333031, Rajasthan, India
[2] Birla Inst Technol & Sci, Dept Biol Sci, Pilani 333031, Rajasthan, India
[3] Birla Inst Technol & Sci, Dept Pharm, Pilani 333031, Rajasthan, India
关键词
D O I
10.1016/S0968-0896(01)00210-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A quantitative structure-activity relationship (QSAR) study has been made on two different series of tetrahydropyrimidinones acting as HIV-1 protease inhibitors. A structural parameter, the first order valence molecular connectivity index ((1)chi (v)), has been used to account for the variation in the activity. The protease inhibition activity as well as the antiviral potency of the compounds are found to be significantly correlated with (1)chi (v) of P-2/P-2' substituents attached to the two nitrogens N1 and N3, suggesting that substituents containing less electronegative and more saturated atoms, meaning thereby the less polar or more hydrophobic substituents, will be more advantageous. Further, if P-2 and P-2' are dissimilar, the former is found to be more effective than the latter. This difference is attributed to a conformational change in the enzyme that may be more favorable to P-2 binding than to P-2' binding. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3059 / 3063
页数:5
相关论文
共 22 条
[1]   Molecular basis of HIV-1 protease drug resistance: Structural analysis of mutant proteases complexed with cyclic urea inhibitors [J].
Ala, PJ ;
Huston, EE ;
Klabe, RM ;
McCabe, DD ;
Duke, JL ;
Rizzo, CJ ;
Korant, BD ;
DeLoskey, RJ ;
Lam, PYS ;
Hodge, CN ;
Chang, CH .
BIOCHEMISTRY, 1997, 36 (07) :1573-1580
[2]  
APPLET K, 1993, PERSPECT DRUG DISCOV, V1, P23
[3]   Stereospecific synthesis, structure-activity relationship, and oral bioavailability of tetrahydropyrimidin-2-one HIV protease inhibitors [J].
De Lucca, GV ;
Liang, J ;
De Lucca, I .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (01) :135-152
[4]   Quantitative structure-activity relationship studies on some anti-human-immunodeficiency-virus-1 (anti-HIV-1) drugs: Viral reverse transcriptase inhibitors [J].
Garg, R ;
Gupta, SP .
JOURNAL OF ENZYME INHIBITION, 1997, 12 (01) :1-12
[5]   Comparative quantitative structure-activity relationship studies on anti-HIV drugs [J].
Garg, R ;
Gupta, SP ;
Gao, H ;
Babu, MS ;
Debnath, AK ;
Hansch, C .
CHEMICAL REVIEWS, 1999, 99 (12) :3525-3601
[6]   Quantitative structure-activity relationship studies on some acyclouridine derivatives acting as anti-HIV-1 drugs [J].
Garg, R ;
Kurup, A ;
Gupta, SP .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1997, 16 (01) :20-24
[7]   Quantitative structure-activity relationship studies on some viral reverse transcriptase inhibitors acting as anti-HIV-1 agents [J].
Garg, R ;
Gupta, SP .
JOURNAL OF ENZYME INHIBITION, 1997, 11 (03) :171-181
[8]   Quantitative structure-activity relationships of some HIV-protease inhibitors [J].
Gupta, SP ;
Babu, MS ;
Kaw, N .
JOURNAL OF ENZYME INHIBITION, 1999, 14 (02) :109-123
[9]   A quantitative structure-activity relationship study on some sulfolanes and arylthiomethanes acting as HIV-1 protease inhibitors [J].
Gupta, SP ;
Babu, MS ;
Sowmya, S .
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (11) :2185-2192
[10]   Quantitative structure-activity relationship studies on cyclic urea-based HIV protease inhibitors [J].
Gupta, SP ;
Babu, MS ;
Garg, R ;
Sowmya, S .
JOURNAL OF ENZYME INHIBITION, 1998, 13 (06) :399-407